Moreover, ALK fusion proteins have been implicated in the pathogenesis of a subset of non-small cell lung carcinomas (ALK+ NSCLC) [4-7] and inflammatory myofibroblastic tumours (ALK+ IMT) [8-10]. This evidence concerns the gene ALK and non-small cell lung carcinoma.